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Abstract
AIM
To establish a threshold value for liver fat content 
between healthy children and those with non-
alcoholic fatty liver disease (NAFLD) by using magnetic 
resonance imaging (MRI), with liver biopsy serving as a 
reference standard.   
METHODS
The study was approved by the local ethics committee, 
and written informed consent was obtained from all 
participants and their legal guardians before the study 
began. Twenty-seven children with NAFLD underwent 
liver biopsy to assess the presence of nonalcoholic 
steatohepatitis. The assessment of liver fat fraction 
was performed using MRI, with a high field magnet 
and 2D gradient-echo and multiple-echo T1-weighted 
sequence with low flip angle and single-voxel point-
resolved ¹H MR-Spectroscopy (¹H-MRS), corrected for 
T1 and T2* decays. Receiver operating characteristic 
curve analysis was used to determine the best cut-
off value. Lin coefficient test was used to evaluate the 
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Comparison of magnetic resonance spectroscopy, proton 
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quantification of liver steatosis in children and adolescents
Observational Study
Michele Di Martino, Lucia Pacifico, Mario Bezzi, Rossella Di Miscio, Beatrice Sacconi, Claudio Chiesa, 
Carlo Catalano
correlation between histology, MRS and MRI-PDFF. A 
Mann-Whitney U -test and multivariate analysis were 
performed to analyze the continuous variables. 
RESULTS
According to MRS, the threshold value between healthy 
children and those with NAFLD is 6%; using MRI-PDFF, 
a cut-off value of 3.5% is suggested. The Lin analysis 
revealed a good fit between the histology and MRS as 
well as MRI-PDFF.
CONCLUSION
MRS is an accurate and precise method for detecting 
NAFLD in children.
Key words: Magnetic resonance spectroscopy; Magnetic 
resonance imaging-PDFF; Obesity; Non-alcoholic fatty 
liver disease; Children
© The Author(s) 2016. Published by Baishideng Publishing 
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Core tip: Differentiating normal from pathologic liver 
fat storage in children could depend on technical 
measurements. Using MR-spectroscopy, a cut-off value 
of 6% demonstrates the best diagnostic performance, 
otherwise magnetic resonance imaging (MRI)-PDFF 
cut-off value of 3.5% better discriminates normal 
weight from obese children. It is confirmed that MRS 
is an accurate and precise method for detecting non-
alcoholic fatty liver disease in children. However, MRI-
PDFF- is a feasible alternative to MRS for quantifying 
liver steatosis.
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INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is emerging 
as a leading cause of chronic liver disease in children 
and adolescents, with a prevalence in the general 
population ranging from 3%-10% in normal weight 
children and 80% in obese children[1-2]. Children 
with NAFLD are usually asymptomatic and garner 
clinical attention because of elevated liver enzymes 
or fatty liver being observed during an ultrasound 
examination. The measurement of liver enzymes alone 
is not sufficient for accurate fatty liver screening in 
overweight children because enzymatic abnormalities 
correlates poorly or not at all with early steatosis[3,4]. 
At present, liver biopsy represents the reference 
standard for diagnosing liver steatosis, although the 
drawbacks of this invasive technique are well known. 
It is associated with morbidity and mortality, it has 
sampling errors, and it is not appropriate for screening, 
longitudinal monitoring, or evaluating treatment 
response[4]. Among the currently available imaging 
modalities, magnetic resonance imaging (MRI) and ¹
H MR spectroscopy (MRS) are the most reproducible, 
safe, and accurate imaging techniques that can be 
used in clinical trials and epidemiologic studies[5]. 
However, MRS has limited clinical applicability or 
availability because it requires sophisticated post-
processing methods, and not every MRI is routinely 
equipped with MRS capabilities. Recent improvements 
in MRI can provide the magnetic resonance imaging-
estimated proton density fat fraction (MRI-PDFF), 
which is a novel biomarker that has demonstrated 
robust correlation and equivalency with MRS[6-10]. 
In addition, MRI-PDFF allows fat mapping of the 
entire liver, and it can be used with any clinical MRI 
platform, whereas MRS measures fat biochemically 
in small regions of interest (ROIs). To the best of our 
knowledge, few studies have used MRS and histology 
to investigate liver fat content in adolescents[11-14]. 
A recently published paper suggested similar fat-
storage between overweight children and adults, and 
the study proposed the same cut-off value for normal 
and pathologic storage[15]. The aim of our study was to 
validate a cut-off value for a pediatric population and 
to correlate the data with laboratory/chemistry results 
and subcutaneous and visceral adipose tissue (SAT 
and VAT) findings.
MATERIALS AND METHODS
The study has been approved by the ethics committee, 
and written informed consent was obtained from all 
participants and their legal guardians before the study 
began. From October 2013 to December 2014, 93 
Caucasian obese children and adolescents [body mass 
index (BMI) above the 95th percentile for age and 
gender] were referred to the Hepatology Outpatient 
Unit of the Department of Pediatrics to confirm or 
rule out the presence of NALFD. All enrolled subjects 
underwent the following measurements: fast blood 
samples [glucose, cholesterol, triglycerides, alanine 
aminotransferase (ALT), aspartate aminotransferase 
(AST), insulin and and γ-glutamyl transferase (γ-GT)] 
and BMI. They also underwent MRI to quantify liver 
steatosis and evaluate SAT and VAT. Five children were 
excluded because their data imaging was not suitable 
for post-processing due to several motion artifacts. 
The study population included 27 patients (16 males 
and 11 females; mean age, 13 years; range, 9-18 
years) who were scheduled for liver biopsy to assess 
the presence of nonalcoholic steatohepatitis (NASH) or 
other liver diseases. Liver biopsy was performed within 
two weeks of the MR examination to avoid any bias, 
such as diet modification. An age- and sex-matched 
control group of 27 healthy Caucasian children, who 
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also had blood chemistry results available, were 
recruited (11 males and 16 females; mean age, 12 
years; range 8-18 years).  
MR imaging 
MRI exams were using a 3T magnet system (GE 
Discovery 750; General Electric Healthcare, Milwaukee, 
WI, United States), with a peak gradient amplitude 
of 50 mT/m and a 200 μsec time to peak. An eight-
element body torso-array coil system was used. 
Before the spectroscopy acquisition, a T2-weighted 
image in the coronal plane (TR 1300, TE 125, FA 
90°, slice thickness 6 mm, matrix 288 × 192) and 
a T1-weighted axial image (TR 4 ms/TE 1 ms, FA 
60°, slice thickness 6 mm, matrix 288 × 192) were 
acquired. To quantify the hepatic fat fraction (HFF), 
an axial breath-hold low-flip angle, T1-weighted, 2D 
multiple-echo, spoiled gradient-echo (GRE) sequence 
(TR5.1/TE from 0.8 to 3.8, flip angle 5°, field of 
view 33 cm; section thickness, 10 mm; intersection 
gap, 0, matrix 128 × 128, acquisition time 2 × 17 
s) was used was used. MRS was performed using 
one 20 mm × 20 mm × 20 mm voxels placed in 
segment Ⅵ-Ⅶ (as close as possible to the site of liver 
biopsy) and avoiding the artifact, major blood vessels 
and biliary ducts. All spectra were obtained in the 
stimulated echo acquisition mode (STEAM, TR 4000 
ms), using a breath hold sequence with an acquisition 
time of approximately 24 s. Field homogeneity 
was automatically adjusted for each voxel. The T2 
relaxation times of both metabolites were determined 
from their peak amplitudes at each echo time using 
an exponential least-squares fitting algorithm, and 
saturation bands were used[8]. For the quantification 
of subcutaneous and visceral adipose tissue (VAT 
and SAT), a 3D GRE T1-weighted sequence on an 
axial plane (TR4.1, TE 1.1, flip angle 15°, matrix 
320 × 192, section thickness 6 mm reconstructed 
3 mm, intersection gap 0) was acquired using the 
IDEAL imaging and Dixon method, which enabled the 
separation between water and fat components using 
the chemical shift MR technique. 
Quantitative analysis 
Images from multiple-echo GRE sequencing were 
subsequently analyzed with software provided by the 
manufacturer (Functool, GE Healthcare, Milwaukee, 
WI, United States); this procedure has been previously 
published[16]. A ROI measuring 2-3 cm in diameter 
was drawn at the same site as the voxel used for 
1H-MRS to avoid extrahepatic fat and large vessels. 
Magnetic resonance spectra were reconstructed on a 
dedicated workstation using the SAGE Dev2 0017.1 
software (General Electric Healthcare, Milwaukee, WI, 
United States). Raw data were zero-filled once, and 
no filter was used. Spectra were referenced to residual 
water and the dominant methylene lipid (-CH3 and 
-CH2) peak at δ 4.8-5.2 and δ 0.9-1.1 and 1.3-1.6 
and 2.1-2.3, respectively. The fat fraction percentage 
(FF) was defined as follows: FF = FA/(FA + WA) x 100, 
where FA is the area under the fat peak and WA is 
the area under the water peak. The fat-only dataset 
from the T1-weighted sequence was transferred to a 
personal computer and analyzed using commercially 
available software (Slice-O-Matic; Tomovision Inc, 
Montreal Canada), the procedure for which has been 
described elsewhere[17,18]. Briefly, SAT and VAT were 
calculated from 5 images extending from 5 cm below 
L4-L5 to 15 cm above L4-L5. A free-form ROI and 
manual thresholding were used to select tissue of fat 
within the subcutaneous and visceral adipose tissue 
(Figure 1).
Histopathologic analysis 
With ultrasound guidance and within two weeks of the 
MR examination, a percutaneous needle liver biopsy 
was performed using an 18-gauge needle, with the 
patients under local anesthesia. To obtain an adequate 
sample, biopsy specimens were obtained twice from 
all patients at two different sites in the right hepatic 
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Figure 1  Subcutaneous and visceral fat measurement technique. A: Sagittal T1-weighted localizer MR image used to select levels for analysis (L1-L2, L2-L3, 
L3-L4, L4-L5, L5-S1); B: Axial T1-weighted MR image with water suppression at the L4-L5 level. Contrast was manually adjusted to select signal from subcutaneous 
(red) and visceral (green) adipose tissue. Area of this fat was calculated by the workstation and summarized with that of other levels.
A B
L1-L2
L2-L3
L3-L4
L4-L5
L5-S1
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Institute Inc., Cary, NC, United States). 
RESULTS
The clinical characteristics of the study population and 
control group are presented in Table 1.
Of the 27 patients who underwent liver biopsy, 11 
(40.7%) children demonstrated grade 1 steatosis, 9 
(33.3%) children demonstrated grade 2 and 7 (26%) 
demonstrated grade 3 (mean, 43.3% ± 26; range, 
10%-90%). The mean lipid content for MRS was 30% ± 
18 (median, 30%; range, 5%-66%), whereas the MRI-
PDFF mean fat fraction was 11% ± 7 (median, 10%; 
range, 1%-33%) (Figure 2). The following HFF values 
were recorded in the control group: MRS (mean, 4.4% 
± 2.5; median, 4%; range, 0.8%-13%) and MRI-PDFF 
(mean, 2.5 ± 2; median, 1.9%; range, 0.7%-11%).
The ROC curve analysis suggested a cut-off value 
of 6% for MRS to discriminate between patients with 
and without steatosis (sensitivity, 92.6%; specificity, 
95.7%; 6 false positive calls); conversely, MRI-PDFF 
suggested a cut-off value of 3.5% (sensitivity, 89%; 
specificity, 88%; 4 false positive calls) (Figure 3).  
For MR spectroscopy, compared with the histology 
results, the Pearson test revealed a correlation of 0.68, 
(P = 0.0001) MRI-PDFF showed slightly lower values 
of 0.63, 0 (P = 0.0005).
Excellent correlation was reported between the 
MR techniques (ρ 0.81, P < 0.0001). Bland Altman 
plot reveals all points within were within the 95% 
limit of agreement, a possible bias encountered in the 
evaluation of MR-PDFF at medium and high level of 
hepatic steatosis (Figure 4). 
Compared to the control group, significantly 
higher BMI (0.0002), VAT (< 0.0001), SAT (0.0001), 
ALT (< 0.0001) and insulin (0.0008) values were 
reported in the study population. Multivariate analysis 
of the quantitative variables demonstrated good 
correlation among VAT, SAT, BMI and insulin in terms 
of predicting liver steatosis (0.80, 0.51, 0.50 and 0.52, 
respectively).  
lobe (Ⅵ and Ⅶ segments). Liver specimens that 
were at least 1.5 cm in length and contained at least 
10-11 complete portal tracts were considered to be 
adequate for histological assessment. Liver steatosis 
was determined by estimating the percentage of fat-
containing hepatocytes on hematoxylin-eosin-stained 
specimens. The grading system for liver steatosis 
was based on the NASH Clinical Research Network 
criteria[19]: grade 0, less than 5% steatosis; grade 1, 
6%-33% steatosis; grade 2, 34%-66% steatosis; 
and grade 3, greater than 66% steatosis. The grading 
system incorporates the accepted normal value for 
histopathologic liver fat, which is less than 5%, and 
it is the standard applied in the clinical assessment 
of severity of liver steatosis by hepatologists and 
gastroenterologists. 
Statistical analysis
To estimate the proper sample size in the correlation 
between the MR imaging and liver biopsy, a power 
analysis was conducted, considering a coefficient 
correlation of 0.6, α error= 0.05 and power 1-β 
= 0.90; the number of subjects was 21. Receiver 
operating characteristic (ROC) curve analysis was 
used to determine the best cut-off values for MRS and 
MRI-PDHFF between the control group and children 
with NAFLD. The Pearson correlation coefficientwas 
calculated among histology, MRS and MRI-PDHFF We 
also estimated agreement by using the 95% limit-of-
agreement method developed by Bland and Altman[20]. 
An analysis of the study population and control groups 
was performed to determine the median ± SD, and 
comparisons were made using the Mann-Whitney U 
test. Multivariate analysis of the continuous variables 
was performed to evaluate which variables were 
useful for predicting liver steatosis. A P value less than 
0.05 was considered to indicate significant difference. 
Statistical analysis was performed using the MedCalc 
Software (V.13.1.2, Acacialaan 22 m 8400, Onsted, 
Belgium), except for the multivariate analysis, which 
was calculated using the JMP software (JMP.11, SAS 
Table 1  Clinical analysis and anthropometry of the study population and the control group
Patients with NAFLD Control group
Median SD 95%CI Median SD 95%CI
BMI 28.71     4.07   26.2-29.58      23.75   3.5   21.86-25.84
ALP 185 104.54 122.21-244.81  219.0 103.00 136.13-303.8
ALT 31   52.21    30-59.5    16.5 50.7      15-20.45
AST 25   25.78 21.14-30.85 22   25.21 20-26
Bilirubin 0.53         0.4074 0.38-0.68        0.59     0.21 0.37-0.67
γ-GT 21   12.24 17.14-28.97  11     9.98 10-12
Insuline 17.61   11.46 12.12-24.14     11.6   3.4   8.17-12.34
Cholesterol 154   38.56 130.44-168.55   142.5 28.8 136-167
Blood glucose 85     7.08 83.14-89.70  83   3.6 81-84
Triglycerides 77   68.86   68.68-114.65     60.5   24.64      50-84.45
VAT 368.351 258.23 334.9-501.7   275.9   76.02 252.4-299.9
SAT 1949.221 1184.9 1743.6-2886.0 1352.9 746.95   840.3-1539.4
1Significantly higher values of BMI (0.0002), VAT (< 0.0001), SAT (0.0001), ALT (< 0.0001) and Insulin (0.0008) were reported. γ-GT: γ-glutamyl transferase; 
BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.
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DISCUSSION
Our results suggest that MRS is an accurate, non-
invasive diagnostic technique for quantifying liver 
steatosis in a pediatric population and that MRI-PDFF 
is a feasible alternative technique. For MRS, the same 
cut-off value of 5% can be used to diagnosis liver 
steatosis in adolescents and adults; in contrast, when 
MRI-PDFF is used to quantify liver steatosis, a cut-
off value of 3.5% is more appropriate. For clinical and 
morphologic analyses, the BMI, VAT, SAT and insulin 
levels should be jointly considered promising tools for 
predicting liver steatosis. 
In a pediatric population, precise measurement 
of the degree of liver steatosis is of clinical interest 
because it has demonstrated an association with 
subclinical signs of atherosclerosis and changes in 
myocardial functions[21-24]. At present, no laboratory 
test can be used for the non-invasive quantification of 
liver steatosis, and ALT values may be elevated only 
in severe cases[25]. Although our analysis reported 
significantly higher levels of ALT and insulin in pre-
Figure 2  Mean lipid content for MR-Spectroscopy. A-C: MRI-PDFF reveals a hepatic fat fraction of 7%, MRS quantified 6.5% of liver steatosis and histological 
analysis 30% of liver steatosis; D-F: Severe hepatic steatosis in a 8-year-old girl: MRII-PDFF 25%, MRS 50% and histologic analysis 90% of liver steatosis 
respectively. 
Figure 3  Receiver operating characteristic curve analysis of MR Spectrscopy (A) and MR imaging-PDFF (B) for discrimination of healthy from non-
alcoholic fatty liver disease children. 
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dicting liver steatosis, only in severe cases were the 
results beyond normal ranges. Anthropometry data 
revealed significantly higher BMI, SAT and VAT values 
in children with NAFLD, as previously described in the 
literature[26,27]; unfortunately, multivariate analysis 
demonstrated only moderate to good values in pre-
dicting liver steatosis (range, 0.80 - 0.50). 
Among the imaging modalities, MRS can provide 
a reliable estimation of the weight fraction of liver 
fat content, and it is now considered to be the most 
accurate non-invasive method; for these reasons, 
it is used extensively in published reports[28-32]. In 
addition, in our experience, MRS demonstrated 
excellent correlation with liver biopsy, with good 
concordance. However, MRS is an expensive and 
primarily research-based tool that is not always 
available[33,34]. MRI-PDFF has been proposed as a 
feasible and simple alternative method for quantifying 
liver steatosis[10,11,35-37]. Our data demonstrated good 
correlation between histology. However a probable 
error should be develop in the differentiation between 
moderate and high grade of steatosis: this limit of 
chemical shift technique is attributed to the presence 
of both water and fat (fat-water signal dominance 
ambiguity) in the single voxel and it is not of clinical 
relevance for patients treatment and managment[38,39]. 
MR-PDFF suggests a lower threshold (3.5%) to define 
hepatic steatosis in children, in agreement with a 
recent publication by Rehm et al[40]. Our multiple-echo 
sequence has several advantages over MRS. First, 
the acquisition time is short, easily fitting within a 
breath hold. Second, the fat content can be measured 
throughout the liver instead of in only one voxel or a 
few voxels; this point is of major importance because 
fat distribution is often heterogeneous. Third, no 
spatial miss-registration errors occur because the OP 
and IP images are acquired simultaneously. Fourth, 
post-processing is considerably easier and faster than 
with MRS. 
Some study limitations should be noted. First, 
the site-to-site reproducibility of our technique was 
evaluated only in segment Ⅶ. Second, our control 
group did not have histologically confirmed healthy 
livers because it would have been unethical to subject 
normal individuals to liver biopsy assessments. 
Thirdly, the three parameters (MRS, MR-PDFF and 
histology) tested in our study assess different aspects 
of steatosis. Histology reveals the percentage of 
hepatocytes that contain vesicles of fat, MR-PDFF 
determines the proportion of mobile protons contained 
within fat molecules and MRS shows the peaks of 
methyl and methylene (-CH2 and CH3) protons in the 
triglyceride molecule.
Finally, Bland-Altman plot analysis demonstrates 
a difficulty of MR-PDFF in the differentiation between 
moderate to severe steatosis; however this drawback 
has not clinical relevance becasuse treatment and 
managmetn of patients is quite similar. 
 In conclusion, MRS was confirmed as the most 
accurate non-invasive method for quantifying liver stea-
tosis in obese children.
Multiple-echo gradient-echo MR sequence may also 
be an easily and rapidly performed technique used to 
quantify liver steatosis in a pediatric population; this 
technique demonstrated excellent agreement with 
MRS and should be considered as reference standard 
in longitudinal studies or clinical trials. Together, BMI, 
VAT, SAT and insulin measurements provide the most 
powerful test for predicting liver steatosis. Further 
studies should be conducted to better match data from 
histological and MRI analyses and to establish MRI 
thresholds for different grades of steatosis.
Figure 4  Evaluation of magnetic resonance imagingestimated-proton 
density fat fraction at medium and high level of hepatic steatosis. A, B: 
Differences between liver fat fraction estimated by using 1H MR spectroscopy 
and triple-echo sequence compared with histology were plotted against means, 
with 95% confidence intervals (Bland-Altman plot); C: All data points were 
within limits of agreement (dotted lines), corresponding to 1.96 SDs from mean. 
MRS: MR-Spectroscopy.
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